Paul Weiss ordered to reveal privileged information from investigation on behalf of bankrupt Chinese medical company

A US court has demanded that Paul Weiss Rifkind Wharton & Garrison hand over privileged information from an internal investigation the law firm oversaw for China Medical Technologies (CMED) to the company’s liquidator.

Get unlimited access to all Global Restructuring Review content